Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting
暂无分享,去创建一个
Julio Saez-Rodriguez | Francesco Iorio | Kosuke Yusa | Rebecca Shepherd | Adam P Butler | Euan A Stronach | Mathew J Garnett | Fiona M Behan | Emanuel Gonçalves | Rachel Pooley | Piers Wilkinson | Elisabeth Chen | Shriram G Bhosle | Charlotte Beaver | Rizwan Ansari | Sarah Harper
[1] Eric S. Lander,et al. Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras , 2017, Cell.
[2] Julio Saez-Rodriguez,et al. A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia , 2016, Cell reports.
[3] Nuno A. Fonseca,et al. Transcription factor activities enhance markers of drug response in cancer , 2017, bioRxiv.
[4] T. Golub,et al. Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting. , 2016, Cancer discovery.
[5] Hans Clevers,et al. Genome-wide CRISPR screens reveal a Wnt–FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors , 2016, Nature Medicine.
[6] M. Wigler,et al. Circular binary segmentation for the analysis of array-based DNA copy number data. , 2004, Biostatistics.
[7] W. Huber,et al. which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .
[8] Nir Hacohen,et al. A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors , 2016, Nature Genetics.
[9] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[10] E. Lander,et al. Identification and characterization of essential genes in the human genome , 2015, Science.
[11] D. Durocher,et al. High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities , 2015, Cell.
[12] S. Ramaswamy,et al. Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.
[13] Neville E. Sanjana,et al. Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells , 2014, Science.
[14] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[15] Emanuel J. V. Gonçalves,et al. Tandem duplications lead to loss of fitness effects in CRISPR-Cas9 data , 2018, bioRxiv.
[16] Kosuke Yusa,et al. Optimised metrics for CRISPR-KO screens with second-generation gRNA libraries , 2017, Scientific Reports.
[17] James E. DiCarlo,et al. RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.
[18] Le Cong,et al. Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.
[19] James M. McFarland,et al. Computational correction of copy-number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells , 2017, bioRxiv.
[20] Meagan E. Sullender,et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 , 2015, Nature Biotechnology.
[21] Emanuel J. V. Gonçalves,et al. A Landscape of Pharmacogenomic Interactions in Cancer , 2016, Cell.
[22] S. Swamy,et al. PICNIC: an algorithm to predict absolute allelic copy number variation with microarray cancer data , 2009, Biostatistics.
[23] Xavier Robin,et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.
[24] Alvis Brazma,et al. The BioStudies database , 2015, Molecular Systems Biology.
[25] N. Kenmochi,et al. The human ribosomal protein genes: sequencing and comparative analysis of 73 genes. , 2002, Genome research.
[26] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[27] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[28] E. S. Venkatraman,et al. A faster circular binary segmentation algorithm for the analysis of array CGH data , 2007, Bioinform..
[29] Yilong Li,et al. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library , 2013, Nature Biotechnology.
[30] E. Lander,et al. Genetic Screens in Human Cells Using the CRISPR-Cas9 System , 2013, Science.
[31] G. Traver Hart,et al. BAGEL: a computational framework for identifying essential genes from pooled library screens , 2015, BMC Bioinformatics.
[32] Julio Saez-Rodriguez,et al. Abstract A44: A landscape of pharmacogenomic interactions in cancer , 2017 .
[33] John G. Doench,et al. In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target , 2017, Nature.
[34] G. Getz,et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.
[35] Joshua M. Korn,et al. CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions. , 2016, Cancer discovery.
[36] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[37] Jun S. Liu,et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens , 2014, Genome Biology.